Helia N. Sanchez, PhD
About Helia N. Sanchez, PhD
Helia N. Sanchez, PhD, serves as the Director of BioPharma Business Development at SOPHiA GENETICS, where she leverages her expertise in immunology and alliance management. With a background in strategic partnerships and a strong foundation in precision medicine, she has held various roles in the biopharmaceutical sector since completing her PhD in Microbiology, Immunology, and Molecular Genetics.
Current Role at SOPHiA GENETICS
Helia N. Sanchez serves as the Director of BioPharma Business Development at SOPHiA GENETICS. She has held this position since 2021 and is based in Boston, Massachusetts. In this role, she focuses on developing strategic partnerships with pharmaceutical companies and enhancing the company's offerings in precision medicine.
Previous Experience at Scipher Medicine
Prior to her current role, Sanchez worked at Scipher Medicine as the Immunology Scientific Lead in Therapeutics Discovery, Search & Evaluation from 2019 to 2020. She also held the position of Immunology Scientist for a brief period in 2019. Her work involved leading preclinical and validation studies aimed at discovering new immunotherapies.
Experience at Foundation Medicine
Sanchez was employed at Foundation Medicine as an Alliance Manager from 2020 to 2021. In this capacity, she managed BioPharma and corporate alliances, leveraging her expertise in alliance management to form strategic partnerships that advance the company's objectives.
Educational Background
Sanchez earned her Doctor of Philosophy (Ph.D.) in Microbiology, Immunology & Molecular Genetics from the Graduate School of Biomedical Sciences at The University of Texas Health Science Center San Antonio, studying from 2014 to 2018. She also holds a Bachelor of Science (B.S.) in Biology from The University of Texas at San Antonio, where she studied from 2010 to 2013.
Expertise in Immunology and Business Development
Sanchez possesses a strong scientific foundation in autoimmunity and immunology, which supports her role in business development. Her expertise includes strategic planning within the field of precision medicine and forming alliances with pharmaceutical companies to foster innovation and collaboration.